FACTORS INFLUENCING THE LOW-DENSITY-LIPOPROTEIN PROFILE IN TYPE-2 DIABETIC-PATIENTS

被引：7

作者：

JAMES, RW

MARINI, M

RUIZ, J

POMETTA, D

机构：

[1] Division de Diabétologie, Geneva

[2] Clinique de Médecine t, Département de Médecine, Hôpital Universitaire, Geneva

来源：

DIABETIC MEDICINE | 1995年 / 12卷 / 01期

关键词：

HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; LDL; HDL; ATHEROSCLEROSIS; TYPE 2 DIABETES MELLITUS; CARDIOVASCULAR RISK FACTORS;

D O I：

10.1111/j.1464-5491.1995.tb02064.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The lipoprotein distribution profile was examined in Type 2 (non-insulin-dependent) diabetic patients (n=52), with particular emphasis on factors influencing low density lipoproteins (LDL). Triglycerides were negatively correlated with LDL-2 (r=0.34, p<0.05) and positively correlated with smaller, denser LDL-3 (r=0.57, p<0.001), This yielded a highly significant, negative correlation between triglycerides and the LDL-2/LDL-3 mass ratio (r=-0.59, p<0.001) which is an indication of the presence of smaller LDL particles. Parameters of glycaemic control, in the form of fasting blood sugar and glycated haemoglobin (HbA(1c)), were also negatively correlated with the LDL-2/LDL-3 mass ratio in univariate analyses; both remained significantly correlated with the mass ratio when corrected for triglycerides. Stepwise multiple regression analysis identified a three-parameter model comprising triglycerides, HbA(1c), and high density lipoprotein cholesterol as best defining the variations in the LDL-2/LDL-3 mass ratio (adjusted r(2) = 0.52). These observations are consistent with an independent impact of diabetes on the LDL distribution profile and the possibility that the latter may be subjected to multiple pathological influences in diabetic patients.

引用

页码：61 / 65

页数：5

共 28 条

[1]

Lindgren FT, Jensen LC, Hatch FT, The isolation and quantitative analysis of serum lipoproteins, Blood Lipids and Lipoproteins. Quantitation, Composition and Metabolism, pp. 182-274, (1972)

[2]

Conversion of very low density lipoprotein to low density lipoprotein, J Clin Invest, 56, pp. 1481-1490, (1975)

[3]

Packard CJ, Munro A, Lorimer AR, Gotto, Shepherd J, Metabolism of apolipoprotein B in large triglyceriderich very low density lipoproteins of normal and hypertriglyceridemic subjects, J Clin Invest, 74, pp. 2178-2192, (1984)

[4]

Krauss RM, Lindgren FT, Ray RM, Interrelationships among subgroups of serum lipoproteins in normal human subjects, Clin Chim Acta, 104, pp. 275-290, (1980)

[5]

Alaupovic P, McConathy WJ, Fesmire J, Tavella M, Bard JM, Profiles of apolipoproteins and apolipoprotein B‐containing lipoprotein particles in dyslipoproteinemias, Clin Chem, 34, (1988)

[6]

Musliner TA, Giotas C, Krauss RM, Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects, Arteriosclerosis, 6, pp. 79-87, (1986)

[7]

Austin MA, Krauss RM, Genetic control of low‐density‐lipoprotein subclasses, Lancet, 2, pp. 592-595, (1986)

[8]

Steiner G, Schwartz L, Shumak S, Poapst M, The association of increased intermediate‐density lipoproteins with smoking and with coronary artery disease, Circulation, 75, pp. 124-130, (1987)

[9]

Tornvall P, Bavenholm P, Landou C, de Faire U, Hamsten A, Relation of plasma levels and composition of apolipoprotein B‐containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction, Circulation, 88, pp. 2180-2189, (1993)

[10]

Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM, Low‐density lipoprotein subclass patterns and risk of myocardial infarction, J Am Med Assoc, 260, pp. 1917-1922, (1988)

← 1 2 3 →